The path to a sale is now clear - We won’t be doing any further...

The path to a sale is now clear - We won’t be doing any further partnering deals.
- Partnering early cost us 2/3rds of Trofinetide’s future value, but was required obviously at the time.
- We now have sufficient funds/revenue and expertise to keep progressing NNZ-2591 in multiple indications.
- Each indication keeps adding substantial future sale value.
- All of this will create huge pressure into a bidding war for our company (we didn’t have this leverage early with Arcadia)
- Maximum Value will be extracted from a sale, not dividends, buy backs or future revenue streams.

I’m happy to wait for the sale (my guess is within next 12-18months) as I’ve been here for 11 years.
Lets enjoy the “home straight”.

All my own thoughts obviously

P.s sorry I don’t post very much, but if I’m at an event that I don’t think anyone else is at I’ll contribute!!!